Greece: Greece introduces new pharmaceutical pricing provisions

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Greece: Greece introduces new pharmaceutical pricing provisions

The legal provisions regarding the pricing of pharmaceutical products have been amended several times during the last decade in an effort to address the issue of very high pharma expenditure and its impact on hospitals and the social security system and to create a stable and predictable reference pricing framework.

The last amendment in the legal provisions was introduced into the Greek legal system by a decision from the minister of health in May 2019.

According to the new provisions, the price of a reference medicinal product will be based on the average of the two lowest prices in the EU, amending the basis previously applicable, which was the three lowest prices in the EU. The price of generic products is 35% lower than that of reference products.

While the new system includes several provisions to ensure a control on the prices as well as to make sure that no product's price is increased more than 10% from its last price, the most important amendment from an IP perspective, is that the provisions existing in the former law, according to which the launch of a generic product in the Greek market would result in a 50% drop in the price of the reference product have been removed.

The launch of a generic product should therefore, contrary to what was applicable before May 2019, have no direct impact, from a statutory perspective, on the price of a reference product, which will be calculated on the basis of the mechanism provided in the new legal provisions.

kilimiris.jpg

Constantinos Kilimiris


Patrinos & Kilimiris7, Hatziyianni Mexi Str.GR-11528 AthensGreeceTel: +30210 7222906, 7222050Fax: +30210 7222889info@patrinoskilimiris.comwww.patrinoskilimiris.com

more from across site and SHARED ros bottom lb

More from across our site

Attorneys explain why there are early signs that the US Supreme Court could rule in favour of ISP Cox in a copyright dispute
A swathe of UPC-related hires suggests firms are taking the forum seriously, as questions over the transitional stage begin
A win for Nintendo in China and King & Spalding hiring a prominent patent litigator were also among the top talking points
Rebecca Newman at Addleshaw Goddard, who live-reported on the seminal dispute, unpicks the trials and tribulations of the case and considers its impact
Attorneys predict how Lululemon’s trade dress and design patent suit against Costco could play out
Lawyers at Linklaters analyse some of the key UPC trends so far, and look ahead to life beyond the transition period
David Rodrigues, who previously worked at an IP boutique, said he may become more involved in transactional work at his new firm
Indian smartphone maker Lava must pay $2.3 million as a security deposit for past sales, as its dispute with Dolby over audio coding SEPs plays out
Powell Gilbert’s opening in Düsseldorf, complete with a new partner hire, continues this summer’s trend of UPC-related lateral movement
IP leaders at Brandsmiths and Bird & Bird, who were on opposing sides at the UK Supreme Court in Iconix v Dream Pairs, unpick the landmark case and its ramifications
Gift this article